Kymriah (tisagenlecleucel) is an immunotherapy medicine used to treat a certain type of acute lymphoblastic leukemia in people who are up to 25 years old.
Kymriah is also used to treat certain adult patients with large B-cell lymphoma.
Kymriah is given after other treatments have failed.
Kymriah is made using white blood cells removed from blood that is drawn from your body through a vein.
Kymriah is available under a special program. You must be registered in the program and understand the risks and benefits of this medicine.
